In this week’s note, we introduce new tools we are using to track the rebirth of the US consumer as a function of infection severity and state policy using real-time debit and credit card data. Additional topics: no evidence yet of material second waves of COVID infection, either around the world or in the US; and a round-up of the latest news on vaccine trials (Moderna, Oxford, Sinovac) and anticoagulants.